Skip to main content
OpenTrials

Clinical trial condition

Follicular Lymphoma

Explore clinical trials studying Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

231 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Follicular Lymphoma trial results

Completed

A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients

NCT01303887

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Ysbyty Gwynedd Bangor, United Kingdom
  • Birmingham Heartlands Birmingham, United Kingdom
  • Royal Bournemouth Hospital Bournemouth, United Kingdom
View all 73 locations
View Trial Details
Completed

Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma

NCT04849351

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Chao-yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
View all 58 locations
View Trial Details
Completed

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

NCT00719888

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

NCT05529524

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Centre Hospitalier de La Cote Basque; Hematologie Bayonne, France
  • Hopital Claude Huriez; Hematologie Lille, France
  • Institut Paoli Calmettes Marseille, France
  • CHU Saint Eloi; Service d'Hématologie Clinique Montpellier, France
View Trial Details
Completed

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

NCT03997968

Conditions
Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
View all 16 locations
View Trial Details
Completed

BTK Inhibitor BGB-3111 in Chinese Participants With Diffuse Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL)

NCT03520920

Conditions
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
  • Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Completed

A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma

NCT03078855

Conditions
Chronic Disease, Disease Attributes, Follicular Lymphoma, +22 more
Locations
  • University of Miami Miami, Florida, United States
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • University of Iowa Iowa City, Iowa, United States
  • Washington University St Louis, Missouri, United States
View Trial Details

Related conditions